Q1 2024 Holdings
Filed 2024-05-15 | 1 holdings | $61.3M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2024-05-17) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | SH | 04351P101 | $1.5B | 10,108,400 | 19.6% |
| Vaxcyte Inc(PCVX) | SH | 92243G108 | $560.4M | 8,203,754 | 7.2% |
| Legend Biotech Corp(LEGN) | SH | 52490G102 | $384.8M | 6,861,097 | 4.9% |
| Janux Therapeutics Inc(JANX) | SH | 47103J105 | $345.1M | 9,165,652 | 4.4% |
| Aerovate Therapeutics Inc | SH | 008064107 | $244.4M | 8,263,982 | 3.1% |
| Rhythm Pharmaceuticals Inc(RYTM) | SH | 76243J105 | $231.0M | 5,330,412 | 3.0% |
| Evolent Health Inc(EVH) | SH | 30050B101 | $188.1M | 5,736,132 | 2.4% |
| Newamsterdam Pharma Co NV(NAMS) | SH | N62509109 | $186.0M | 7,864,000 | 2.4% |
| Rxsight Inc(RXST) | SH | 78349D107 | $177.6M | 3,442,825 | 2.3% |
| Tyra Biosciences Inc(TYRA) | SH | 90240B106 | $170.8M | 10,416,609 | 2.2% |
| Edgewise Therapeutics Inc(EWTX) | SH | 28036F105 | $162.5M | 8,909,091 | 2.1% |
| 4D Molecular Therapeutics in(FDMT) | SH | 35104E100 | $160.9M | 5,051,511 | 2.1% |
| Biogen Inc(BIIB) | SH | 09062X103 | $159.7M | 740,727 | 2.0% |
| Pepgen Inc(PEPG) | SH | 713317105 | $157.1M | 10,689,545 | 2.0% |
| Geron Corp(GERN) | SH | 374163103 | $152.5M | 46,202,425 | 2.0% |
| 89Bio Inc(ETNBGBP) | SH | 282559103 | $148.6M | 12,766,948 | 1.9% |
| Dyne Therapeutics Inc(DYN) | SH | 26818M108 | $140.7M | 4,954,779 | 1.8% |
| Apogee Therapeutics Inc(APGE) | SH | 03770N101 | $131.4M | 1,977,901 | 1.7% |
| DAY One Biopharmaceuticals I(DAWN) | SH | 23954D109 | $129.0M | 7,809,852 | 1.7% |
| Nkarta Inc(NKTX) | SH | 65487U108 | $116.8M | 10,805,129 | 1.5% |
| Wave Life Sciences LTD(WVE) | SH | Y95308105 | $112.3M | 18,202,009 | 1.4% |
| ARS Pharmaceuticals Inc(SPRY) | SH | 82835W108 | $111.0M | 10,860,977 | 1.4% |
| Fulcrum Therapeutics Inc(FULC) | SH | 359616109 | $109.6M | 11,609,704 | 1.4% |
| Verona Pharma PLC(VRNA) | SH | 925050106 | $101.7M | 6,317,990 | 1.3% |
| Lenz Therapeutics Inc(LENZ) | SH | 52635N103 | $93.3M | 4,178,823 | 1.2% |
| Inhibrx Inc(INBXUSD) | SH | 45720L107 | $91.9M | 2,629,837 | 1.2% |
| Avidity Biosciences Inc(RNA) | SH | 05370A108 | $83.8M | 3,282,180 | 1.1% |
| Axsome Therapeutics Inc(AXSM) | SH | 05464T104 | $79.8M | 1,000,000 | 1.0% |
| Longboard Pharmaceuticals in | SH | 54300N103 | $71.0M | 3,289,119 | 0.9% |
| Dianthus Therapeutics Inc(DNTH) | SH | 252828108 | $70.0M | 2,333,000 | 0.9% |
| GH Research PLC(GHRS) | SH | G3855L106 | $66.6M | 6,251,714 | 0.9% |
| Structure Therapeutics Inc(GPCR) | SH | 86366E106 | $64.7M | 1,510,362 | 0.8% |
| Mineralys Therapeutics Inc(MLYS) | SH | 603170101 | $62.6M | 4,850,984 | 0.8% |
| Astria Therapeutics Inc(CATBUSD) | SH | 04635X102 | $62.1M | 4,413,150 | 0.8% |
| CG Oncology Inc(CGON)A | SH | 156944100 | $61.3M | 1,397,433 | 100.0% |
| Acumen Pharmaceuticals Inc(ABOS) | SH | 00509G209 | $60.5M | 14,932,063 | 0.8% |
| Iteos Therapeutics Inc(5E7) | SH | 46565G104 | $60.3M | 4,417,259 | 0.8% |
| Solid Biosciences Inc(SLDB) | SH | 83422E204 | $57.7M | 4,330,446 | 0.7% |
| Madrigal Pharmaceuticals Inc(MDGL) | SH | 558868105 | $54.6M | 204,500 | 0.7% |
| VOR Biopharma Inc | SH | 929033108 | $53.9M | 22,748,880 | 0.7% |
| Praxis Precision Medicines I(PRAX) | SH | 74006W207 | $50.5M | 828,380 | 0.6% |
| Urogen Pharma LTD(URGN) | SH | M96088105 | $46.3M | 3,083,430 | 0.6% |
| Larimar Therapeutics Inc(LRMR) | SH | 517125100 | $45.9M | 6,045,351 | 0.6% |
| Cytek Biosciences Inc(CTKB) | SH | 23285D109 | $45.7M | 6,809,404 | 0.6% |
| C4 Therapeutics Inc(CCCC) | SH | 12529R107 | $39.9M | 4,878,000 | 0.5% |
| Werewolf Therapeutics Inc(HOWL) | SH | 95075A107 | $39.8M | 6,144,881 | 0.5% |
| Enliven Therapeutics Inc(ELVN) | SH | 29337E102 | $37.3M | 2,122,465 | 0.5% |
| Eliem Therapeutics Inc(CLYM) | SH | 28658R106 | $36.0M | 13,150,849 | 0.5% |
| Acrivon Therapeutics Inc(ACRV) | SH | 004890109 | $34.4M | 4,810,508 | 0.4% |
| Taysha Gene Therapies Inc(TSHA) | SH | 877619106 | $31.2M | 10,872,503 | 0.4% |